🇺🇸 FDA
Pipeline program

Yang Yin Fu Zheng Jie Du therapy

BeijingDHYZY

Phase 1 small_molecule completed

Quick answer

Yang Yin Fu Zheng Jie Du therapy for Hepatocellular Carcinoma is a Phase 1 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Hepatocellular Carcinoma
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials